Global Cell therapy Processing
Market Report
2025
The global Cell therapy Processing market size will be USD 4715.5 million in 2024. Increasing demand for advanced and personalized treatments for various chronic and genetic diseases is expected to boost sales to USD 20314.33 million by 2031, with a Compound Annual Growth Rate (CAGR) of 23.20% from 2024 to 2031.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Cell therapy Processing Market Report 2025.
According to Cognitive Market Research, the global Cell therapy Processing market size will be USD 4715.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 23.20% from 2024 to 2031.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 23.2% |
North America Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.4% |
United States Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.2% |
Canada Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.2% |
Mexico Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.9% |
Europe Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.7% |
United Kingdom Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.5% |
France Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 20.9% |
Germany Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.9% |
Italy Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.1% |
Russia Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 20.7% |
Spain Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 20.8% |
Rest of Europe Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 20.4% |
Asia Pacific Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 25.2% |
China Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 24.7% |
Japan Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 23.7% |
India Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 27% |
South Korea Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 24.3% |
Australia Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 24.9% |
Rest of APAC Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 25% |
South America Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.6% |
Brazil Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 23.2% |
Argentina Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 23.5% |
Colombia Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.4% |
Peru Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.8% |
Chile Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.9% |
Rest of South America Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.7% |
Middle East Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.9% |
Egypt Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 23.2% |
Turkey Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 22.4% |
Rest of Middle East Cell therapy Processing Market Sales Revenue | 121212 | 121212 | 121212 | 21.9% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Offering Type Outlook: |
|
Market Split by Application Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Cell therapy Processing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cell therapy Processing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cell therapy processing involves the manipulation, isolation, expansion, and differentiation of cells to treat various diseases, such as cancer, genetic disorders, and autoimmune diseases. This process utilizes living cells, which are either derived from the patient (autologous) or from a donor (allogeneic), to regenerate or repair damaged tissues or to modify immune responses. The Cell Therapy Processing Market is witnessing significant growth due to a combination of factors, including increasing healthcare investments, advancements in biotechnology, and the rising prevalence of chronic and genetic diseases. The market is driven by the demand for personalized medicine, which leverages cell therapies to offer more effective and tailored treatment solutions. Additionally, continuous advancements in stem cell research, gene therapy, and regenerative medicine are contributing to the expansion of this market.
In July 2022, Achilles Therapeutics declared that it had been awarded a USD 4.2 million Horizon Europe, the EU’s key funding initiative for research and innovation. This funding was awarded to advance personalized therapy manufacturing. (Source: https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-lead-horizon-europe-funded-consortium)
The rising incidence of chronic and genetic diseases, such as cancer, autoimmune disorders, and genetic conditions, is a significant driver for the cell therapy processing market. As traditional treatments often fail to provide effective, long-term solutions, there is a growing demand for advanced therapies that can target the root causes of these diseases. Cell therapies, including stem cell and gene therapies, are becoming an essential part of personalized medicine, offering tailored treatments with the potential for curing conditions that were previously considered untreatable. For instance, May 2022, Sernova and Evotec entered into a collaboration for development of cell therapy to be used for the treatment of insulin-dependent diabetes using induced pluripotent stem cells (iPSC)-based therapeutics
Ongoing research and innovations in regenerative medicine and stem cell technologies are driving significant growth in the cell therapy processing market. Scientific breakthroughs are leading to improved understanding and development of cellular therapies for various applications, including tissue repair and organ regeneration. These advancements not only enhance the efficacy of cell therapies but also increase the number of clinical trials and approvals, thereby expanding the market. As regenerative medicine gains more recognition and acceptance, its applications in treating complex diseases are expected to rise, further fueling market demand.
One of the major challenges in the cell therapy processing market is the high manufacturing costs associated with the production of cell-based therapies. The complex nature of cell processing, which includes isolation, expansion, and differentiation of cells, often requires specialized equipment, highly skilled personnel, and strict adherence to regulatory standards. These factors contribute to significant operational expenses, limiting accessibility to these treatments. The expensive nature of manufacturing also affects the affordability of therapies, especially in emerging markets, posing a barrier to broader adoption and hindering the market's full potential.
Covid-19 pandemic had a significant impact on the Cell Therapy Processing Market, causing both disruptions and opportunities. During the initial phases of the pandemic, many clinical trials and research activities were delayed or put on hold due to lockdowns, travel restrictions, and diversion of healthcare resources to manage COVID-19 cases. This led to a slowdown in cell therapy development and manufacturing. However, the pandemic also accelerated interest in cell therapies for treating viral infections, including COVID-19 itself, as well as for developing regenerative therapies for post-viral recovery. Additionally, the increased focus on personalized medicine and biopharmaceutical innovations during the pandemic has strengthened the long-term growth prospects for the market, driving investment and research into cell-based therapies.
We have various report editions of Cell therapy Processing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The Cell Therapy Processing Market is highly competitive, with numerous established companies, innovative startups, and research institutions playing a significant role in its development. Key players in this market are focusing on advancements in technology, strategic partnerships, and expanding their product portfolios to maintain a competitive edge.
In October 2023, Nkarta, Inc. announced the FDA's approval of an IND application to investigate NKX019, its allogeneic, CD19-directed CAR NK cell therapy candidate, to cure lupus nephritis. (Source: https://ir.nkartatx.com/news-releases/news-release-details/nkarta-receives-fda-clearance-ind-application-nkx019-lupus) In June 2023, Vertex Pharmaceuticals Incorporated and Lonza revealed a joint venture to facilitate the manufacturing of Vertex's portfolios of investigational stem cell therapies. These therapies are designed to aid individuals with Type 1 Diabetes (T1D), with a specific focus on the VX-880 and VX-264 programs currently undergoing clinical trials. (Source: https://news.vrtx.com/news-releases/news-release-details/vertex-and-lonza-build-dedicated-manufacturing-facility-type-1)
Top Companies Market Share in Cell therapy Processing Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominates the Cell Therapy Processing Market due to several key factors, including advanced healthcare infrastructure, high research and development (R&D) investments, and a well-established biopharmaceutical industry. The region is home to numerous leading biotechnology and pharmaceutical companies, which actively invest in the development and commercialization of cell therapies.
Asia-Pacific is the fastest-growing region in the Cell Therapy Processing Market due to a combination of factors, including rapidly improving healthcare infrastructure, increasing investment in biotechnology, and a large, diverse patient population with unmet medical needs. The region's growing focus on advancing regenerative medicine and cell therapies, supported by government initiatives and funding, is driving market growth.
The current report Scope analyzes Cell therapy Processing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1886.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.4% from 2024 to 2031.
According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1414.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2031.
According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1084.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 25.2% from 2024 to 2031.
According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 235.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2031.
According to Cognitive Market Research, the global Cell therapy Processing market size was estimated at USD 4715.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 94.31 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.9% from 2024 to 2031..
Global Cell therapy Processing Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cell therapy Processing Industry growth. Cell therapy Processing market has been segmented with the help of its Offering Type Outlook:, Application Outlook: , and others. Cell therapy Processing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Cell therapy Processing Market?
According to Cognitive Market Research, the Products segment is the dominant category due to the increasing demand for specialized cell culture media, reagents, and kits used in cell isolation, expansion, and differentiation. These products are essential for both research and commercial-scale production of cell therapies. Their widespread use in various therapeutic areas, such as cancer treatment and regenerative medicine, makes them a vital component in the development of advanced therapies.
The Services segment is the fastest-growing category in the Cell Therapy Processing Market. This growth is driven by the increasing demand for outsourced manufacturing and cell processing services provided by contract development and manufacturing organizations (CDMOs). These services help companies scale up production, comply with regulatory standards, and optimize the efficiency of cell therapy processes.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cell therapy Processing Industry. Request a Free Sample PDF!
According to Cognitive Market Research, The Cancer application segment is the dominant category in the Cell Therapy Processing Market, driven by the increasing prevalence of cancer worldwide and the rising demand for innovative treatments. Cell therapies, particularly immunotherapies like CAR-T (Chimeric Antigen Receptor T-cell) therapies, have shown promising results in treating various cancers, which contributes to the segment’s dominance.
The Neurological Disorders application segment is the fastest-growing in the Cell Therapy Processing Market due to the increasing focus on developing regenerative therapies for diseases like Alzheimer's, Parkinson's, and spinal cord injuries. The growing prevalence of neurological disorders, coupled with advances in stem cell research and gene therapies, is propelling the demand for cell-based treatments.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Offering Type Outlook: | Products, Services, Software |
Application Outlook: | Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Others |
List of Competitors | Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc, JCR Pharmaceuticals Co., Ltd., JW Therapeutics, Atara Biotherapeutics, Anterogen Co., Ltd., MEDIPOST, S. BIOMEDICS, Aurion Biotech, Holostem Terapie Avanzate S.r.l, Nkarta, Inc. |
This chapter will help you gain GLOBAL Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review Global Cell therapy Processing Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review North America Cell therapy Processing Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review Europe Cell therapy Processing Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review Asia Pacific Cell therapy Processing Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review South America Cell therapy Processing Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review Middle East Cell therapy Processing Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Cell therapy Processing. Further deep in this chapter, you will be able to review Middle East Cell therapy Processing Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Cell therapy Processing. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Offering Type Outlook: Analysis 2019 -2031, will provide market size split by Offering Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Offering Type Outlook: Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Outlook: Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cell therapy Processing market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Products have a significant impact on Cell therapy Processing market? |
What are the key factors affecting the Products and Services of Cell therapy Processing Market? |
What is the CAGR/Growth Rate of Cardiovascular Devices during the forecast period? |
By type, which segment accounted for largest share of the global Cell therapy Processing Market? |
Which region is expected to dominate the global Cell therapy Processing Market within the forecast period? |